Two retail pharmacy giants have been sued in separate class action lawsuits for their alleged role in soaring prescription drug prices—an indication that plaintiffs lawyers may be assuming a role traditionally left to legislators.
In complaints filed on Monday and Wednesday, consumers accused CVS Health of Woonsocket, Rhode Island, and Walgreens Boots Alliance Inc. of Deerfield, Illinois, respectively, of colluding with pharmacy benefit managers to sell certain generic drugs at a higher cost if they are purchased with insurance.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
